Early health technology assessment of diagnostic cardiology technology for reperfusion VF prediction of STEMI patients indicated for PCI
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F25%3A00379261" target="_blank" >RIV/68407700:21460/25:00379261 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1007/s12553-024-00933-9" target="_blank" >https://doi.org/10.1007/s12553-024-00933-9</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s12553-024-00933-9" target="_blank" >10.1007/s12553-024-00933-9</a>
Alternative languages
Result language
angličtina
Original language name
Early health technology assessment of diagnostic cardiology technology for reperfusion VF prediction of STEMI patients indicated for PCI
Original language description
Purpose The study deals with eHTA of new technology for STEMI patients indicated for PCI treatment, which contains diagnostic of rVF risks and medication to prevent rVF in at-risk patients above standard approved procedure. Due to the recommended medication procedure for STEMI patients with identified high rVF risks during PCI and its effectiveness have not been established the goal is to find out what level of medication effectiveness which will be sufficient for the cost-effectiveness of the new technology. Methods Scenarios where the effectiveness of rVF protecting medication administered to predisposed STEMI patients undergoing PCI varies from 5 to 95% were analyzed. Cost-effectiveness was evaluated by the CEA. Results The determined minimum effectiveness of rVF protecting medication to achieve the technology and procedure cost-effectiveness is 7.54%. Even if medication efficacy is at least 39.58%, the technology is “dominant” and the ICER is in the South-east [SE] quadrant. Conclusions Cost-effectiveness analysis show that for all scenarios modeled, except the 5% medication effectiveness scenario, the technology appears to be cost-effective. so such new technology will probably be very attractive for investors.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
20601 - Medical engineering
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Health and Technology
ISSN
2190-7188
e-ISSN
2190-7196
Volume of the periodical
15
Issue of the periodical within the volume
2
Country of publishing house
DE - GERMANY
Number of pages
9
Pages from-to
377-385
UT code for WoS article
001390194500001
EID of the result in the Scopus database
2-s2.0-105002994472